RIO DE JANEIRO, BRAZIL - Oxford University announced Tuesday that it is testing antiparasitic drug Ivermectin as a potential treatment for Covid-19, as part of a British government-backed study that seeks to aid the recovery of patients in non-hospital settings.
Ivermectin resulted in reduced viral replication in laboratory studies, the university said, adding that a small pilot study showed that administering the drug early could reduce . . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here